Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-07-31
1990-11-06
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548337, A61K 31415, C07D23384
Patent
active
049687131
ABSTRACT:
A method for inhibiting transglutaminase activity, especially Factor XIIIa activity with certain imidazole compounds is described. The imidazole compounds are those selected from
REFERENCES:
patent: 4218476 (1980-08-01), Joensson et al.
patent: 4265898 (1981-05-01), Horstmann et al.
Kister et al., Can. J. Chem. 57,813 (1979).
Kister et al., Can. J. Chem. 57,822 (1979).
Baldwin John J.
Claremon David A.
Remy David C.
Caruso Charles M.
Datlow Philip I.
Merck & Co. , Inc.
Robertson Alice O.
Shah Mukund J.
LandOfFree
Certain imidazole compounds as transglutaminase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain imidazole compounds as transglutaminase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain imidazole compounds as transglutaminase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1307214